No abstract available
Publication types
-
Clinical Trial
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Biomarkers
-
Bone Density Conservation Agents / therapeutic use*
-
Bone Resorption / drug therapy*
-
Calcitriol / therapeutic use
-
Calcium / therapeutic use
-
Chronic Kidney Disease-Mineral and Bone Disorder / blood
-
Chronic Kidney Disease-Mineral and Bone Disorder / drug therapy*
-
Chronic Kidney Disease-Mineral and Bone Disorder / etiology
-
Cinacalcet
-
Contraindications
-
Denosumab
-
Drug Therapy, Combination
-
Female
-
Humans
-
Hydroxycholecalciferols / therapeutic use
-
Hypocalcemia / chemically induced
-
Hypocalcemia / prevention & control
-
Kidney Failure, Chronic / complications
-
Kidney Failure, Chronic / therapy
-
Male
-
Middle Aged
-
Naphthalenes / therapeutic use
-
Osteoclasts / drug effects
-
Prospective Studies
-
RANK Ligand / immunology
-
Renal Dialysis* / adverse effects
Substances
-
Antibodies, Monoclonal, Humanized
-
Biomarkers
-
Bone Density Conservation Agents
-
Hydroxycholecalciferols
-
Naphthalenes
-
RANK Ligand
-
TNFSF11 protein, human
-
Denosumab
-
Calcitriol
-
Calcium
-
Cinacalcet
-
alfacalcidol